UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 17, 2018
THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)
____________________
| Delaware | 1-07151 | 31-0595760 |
| (State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer |
| incorporation) | Identification No.) |
1221 Broadway, Oakland, California 94612-1888
(Address of principal executive offices) (Zip code)
(510) 271-7000
(Registrant's telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
(b) In the original Current Report on Form 8-K filed on January 22, 2018 (the “Original 8-K”), The Clorox Company (the “Company”) disclosed that Stephen M. Robb, Executive Vice President – Chief Financial Officer of the Company, had provided notice of his intention to retire from the Company on March 31, 2018. The Original 8-K stated that Mr. Robb would continue in an advisory capacity through the end of the fiscal year (June 30, 2018). The Company is filing this amendment to the Original 8-K to disclose that Mr. Robb will now continue in an advisory capacity through September 30, 2019. In accordance with the amendments to the Company’s Supplemental Executive Retirement Plan as described in the Current Report on Form 8-K filed on March 30, 2018, Mr. Robb will continue to accrue age and service credit and will not receive any additional compensation for serving in an advisory capacity.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| THE CLOROX COMPANY | ||
| Date: March 30, 2018 | By: | /s/ Laura Stein |
| Executive Vice President – | ||
| General Counsel and Corporate Affairs | ||